Qiming Venture Partners' portfolio company LanzaTech Lists on Nasdaq
Rhea-AI Summary
LanzaTech NZ, Inc. completed its business combination with AMCI Acquisition Corp. II and began trading on Nasdaq as LanzaTech Global, Inc. (NASDAQ: LNZA) on February 10, 2023. The IPO was priced at $10.00 per share, valuing the company at $2 billion. LanzaTech specializes in carbon capture technology, converting waste carbon into sustainable fuels and materials. It has launched commercial carbon refining plants, producing over 47 million gallons of ethanol and mitigating over 240,000 tons of CO2. The company collaborates with brands like Lululemon and Unilever to promote sustainable solutions.
Positive
- Successfully listed on Nasdaq with a market cap of $2 billion.
- Has launched multiple commercial plants to produce sustainable fuels and mitigate CO2 emissions.
Negative
- None.
News Market Reaction
On the day this news was published, LNZA declined 5.21%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
As
As sustainability becoming a global consensus, more companies are pledging carbon-neutral or zero-carbon goals, and environment-conscious consumer market is growing rapidly. LanzaTech partnered with major brands such as Lululemon, Total and L'Oreal, and Unilever to deliver world's first sustainable packaging and materials leveraging captured carbon emissions instead of fossil fuels, supporting and creating a more sustainable future.
"The successful IPO marks a new milestone for
About
Founded in 2006,
Currently,
Since our debut, we have backed over 480 fast-growing and innovative companies. Over 180 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX,
Many of our portfolio companies are today's most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, New Horizon Health, Venus MedTech, Sanyou Medical, AmoyDx, Berry Genomics, SinocellTech, Yuanxin Technology, Caidya, Belief BioMed, WeRide, Biren Technology and UBTech among many others.
View original content:https://www.prnewswire.com/news-releases/qiming-venture-partners-portfolio-company-lanzatech-lists-on-nasdaq-301744577.html
SOURCE